Procter & Gamble (NYSE:PG) PT Raised to $182.00 at Jefferies Financial Group

Procter & Gamble (NYSE:PG) had its target price lifted by stock analysts at Jefferies Financial Group from $175.00 to $182.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s target price would suggest a potential upside of 12.69% from the stock’s current price.

Several other brokerages also recently commented on PG. UBS Group lifted their target price on shares of Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a report on Wednesday, January 24th. The Goldman Sachs Group assumed coverage on shares of Procter & Gamble in a report on Friday, March 1st. They issued a “neutral” rating and a $168.00 price objective for the company. Royal Bank of Canada boosted their price objective on shares of Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a report on Wednesday, January 24th. Wells Fargo & Company boosted their price objective on shares of Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a report on Wednesday, January 24th. Finally, Raymond James boosted their price objective on shares of Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a report on Wednesday, January 24th. Seven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $168.88.

Procter & Gamble Stock Up 0.6 %

Procter & Gamble stock opened at $161.50 on Monday. The firm has a market capitalization of $380.01 billion, a PE ratio of 26.39, a P/E/G ratio of 3.19 and a beta of 0.44. The company’s 50-day moving average is $159.32 and its 200-day moving average is $153.26. Procter & Gamble has a fifty-two week low of $141.45 and a fifty-two week high of $163.14. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.69 and a quick ratio of 0.48.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.10. The company had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.77%. Procter & Gamble’s revenue for the quarter was up .6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.37 EPS. Sell-side analysts anticipate that Procter & Gamble will post 6.53 earnings per share for the current year.

Insider Buying and Selling

In other Procter & Gamble news, COO Shailesh Jejurikar sold 31,275 shares of the firm’s stock in a transaction on Thursday, January 25th. The shares were sold at an average price of $154.90, for a total value of $4,844,497.50. Following the transaction, the chief operating officer now directly owns 9,623 shares of the company’s stock, valued at $1,490,602.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Ma. Fatima Francisco sold 45,000 shares of the stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $156.00, for a total value of $7,020,000.00. Following the completion of the sale, the chief executive officer now owns 973 shares in the company, valued at $151,788. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Shailesh Jejurikar sold 31,275 shares of the stock in a transaction dated Thursday, January 25th. The shares were sold at an average price of $154.90, for a total transaction of $4,844,497.50. Following the completion of the sale, the chief operating officer now owns 9,623 shares of the company’s stock, valued at approximately $1,490,602.70. The disclosure for this sale can be found here. Insiders have sold a total of 103,771 shares of company stock valued at $16,292,467 over the last ninety days. 0.17% of the stock is owned by corporate insiders.

Institutional Trading of Procter & Gamble

Several institutional investors and hedge funds have recently made changes to their positions in the company. Wellington Management Group LLP increased its holdings in Procter & Gamble by 9.4% during the third quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock worth $5,193,916,000 after buying an additional 3,047,557 shares during the last quarter. Northern Trust Corp increased its holdings in Procter & Gamble by 2.3% during the third quarter. Northern Trust Corp now owns 29,313,150 shares of the company’s stock worth $4,275,616,000 after buying an additional 670,862 shares during the last quarter. Norges Bank purchased a new position in shares of Procter & Gamble in the fourth quarter worth about $3,956,117,000. Charles Schwab Investment Management Inc. increased its stake in shares of Procter & Gamble by 1.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 16,209,425 shares of the company’s stock worth $2,336,552,000 after purchasing an additional 206,165 shares in the last quarter. Finally, Royal Bank of Canada increased its stake in shares of Procter & Gamble by 3.2% in the third quarter. Royal Bank of Canada now owns 11,170,305 shares of the company’s stock worth $1,629,299,000 after purchasing an additional 346,925 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.